Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any
discrepancy between this translated document and the original Japanese document, the latter shall prevail.

Summary of Non-Consolidated Financial Results
for the Six Months Ended September 30, 2023
(Based on Japanese GAAP)
October 31, 2023
Company name:
DAIKEN MEDICAL CO., LTD.
Stock exchange listing: Tokyo
Stock code:
Representative:

7775
President

URL

https://www.daiken-iki.co.jp
Keiichi Yamada

Inquiries:

Chief of Headquarters BusinessAdministration Department

Takuwa Ryo

TELScheduled date to file Quarterly Securities Report:
Scheduled date to commence dividend payments:

November 1, 2023
December 1, 2023

Preparation of supplementary material on quarterly financial results:
Holding of quarterly financial results meeting:

Yes
Yes

0725-30-3150(for institutional investors and analysts)(Amounts less than one million yen are rounded down)

1. Non-consolidated financial results for the six months ended September 30, 2023 (from April 1, 2023 to September 30, 2023)(1) Non-consolidated operating results (cumulative)
Percentages indicate year-on-year changes
Net sales
Six months ended September 30, 2023
Six months ended September 30, 2022

Millions of yen
4,824
4,454

Operating profit% Millions of yen
8.3
745
9.0605

Earnings per share

Ordinary profit% Millions of yen
23.2
750
7.0605%25.2
7.3

Diluted earnings per share

Yen
18.72
14.94

Six months ended September 30, 2023
Six months ended September 30, 2022

Profit% Millions of yen
24.0537
7.0429Yen––(2) Non-consolidated financial positionTotal assets

Net assets

Millions of yen
11,24811,013As of September 30, 2023
As of March 31, 2023

Equity ratio

Millions of yen
6,824
6,597%
60.4
59.7

2. Cash dividends
Annual dividends per share

Year ended March 31, 2023
Year ending March 31, 2024

1st quarter-end

2nd quarter-end

3rd quarter-end

Fiscal year-end

Yen––

Yen
9.00
9.00

Yen–

Yen
11.00

Yen
20.00

–

11.00

20.00

Year ending March 31, 2024 (Forecast)Total

3. Forecast of non-consolidated financial results for the year ending March 31, 2024 (from April 1, 2023 to March 31, 2024)
Percentages indicate year-on-year changes
Net sales
Full year

Millions of yen
9,600

Operating profit% Millions of yen
5.1
1,300

Ordinary profit% Millions of yen
23.3
1,300

1Profit% Millions of yen
23.4
900

Earnings per share%
26.4

Yen
31.33

4. Notes(1) Application of special accounting methods for preparing quarterly non-consolidated financial statements: Yes(2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
NoChanges in accounting policies due to revisions to accounting standards and other regulations:
Changes in accounting policies due to other reasons:
Changes in accounting estimates:

NoNo

Restatement of prior period financial statements:

No(3) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2023

31,840,000 shares As of March 31, 2023

31,840,000 shares

Number of treasury shares at the end of the period
As of September 30, 2023

3,111,561 shares As of March 31, 2023

3,111,561 shares

Average number of shares during the period (cumulative from the beginning of the fiscal year)
Six months ended September 30, 2023

28,728,439 shares Six months ended September 30, 2022

228,728,441 shares

Quarterly non-consolidated financial statements
Non-consolidated balance sheets(Thousands of yen)
As of March 31, 2023

As of September 30, 2023

AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade

2,516,212
1,300,880

2,657,507
1,298,684

Electronically recorded monetary claims - operating
Finished goods

1,229,646
1,004,2661,285,306
1,016,134

Work in process
Raw materials

88,420422,011

106,859454,950

Other
Allowance for doubtful accounts

77,217(94)

83,750(94)

6,638,560

6,903,097

1,861,600
1,703,670

1,818,757
1,703,670

Total current assets
Non-current assets
Property, plant and equipment
Buildings, net
Land
Other, net
Total property, plant and equipment
Intangible assets
Investments and other assets
Deferred tax assets
Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets

3504,967

513,8184,070,238

4,036,247

9,406

8,187

230,596

230,596

89,253(24,650)

95,216(24,650)

295,198

301,161

4,374,843

4,345,596

11,013,404

11,248,693

(Thousands of yen)
As of March 31, 2023

As of September 30, 2023

Liabilities
Current liabilities
Notes and accounts payable - trade549,495

527,249

626,308
1,000,000

637,161
1,200,000

Current portion of long-term borrowings
Income taxes payable

659,972
242,047

649,972
234,940

Accrued expenses
Other70,312
221,32973,573284,283

Total current liabilities

3,369,464

3,607,181

Non-current liabilities
Long-term borrowings

1,013,395

793,40933,39723,786

Electronically recorded obligations - operating
Short-term borrowings

Other
Total non-current liabilities

1,046,792

817,195

4,416,257

4,424,377

Share capital
Capital surplus

495,875
400,875

495,875
400,875

Retained earnings
Treasury shares

7,506,089(1,826,583)

7,727,753(1,826,583)

Total shareholders' equity

6,576,256

6,797,920

Total liabilities
Net assets
Shareholders' equity

Share acquisition rights
Total net assets
Total liabilities and net assets

420,890

26,396

6,597,146

6,824,316

11,013,404

11,248,693

Non-consolidated statements of income (cumulative)(Thousands of yen)Six months ended

Six months ended

September 30, 2022

September 30, 2023

Net sales
Cost of sales

4,454,775
2,613,071

4,824,637
2,831,332

Gross profit

1,841,703

1,993,304

Selling, general and administrative expenses

1,236,682

1,247,989

605,021745,314

Interest income
Compensation income

0733

01,664Foreign exchange gains
Gain on forfeiture of unclaimed dividends

711
261

2,234
307

Gain on sale of scraps
Miscellaneous income–
271

2,188
910

1,978

7,305

1,971

2,407

–

0

Operating profit
Non-operating income

Total non-operating income
Non-operating expenses
Interest expenses
Other
Total non-operating expenses
Ordinary profit
Extraordinary losses
Loss on retirement of non-current assets
Total extraordinary losses

1,971

2,407

605,028

750,213

50

57

50

57

Profit before income taxes

604,978

750,156

Income taxes

175,694

212,480

Profit429,284

537,6765

Non-consolidated statements of cash flows(Thousands of yen)Six months ended

Six months ended

September 30, 2022

September 30, 2023

Cash flows from operating activities
Profit before income taxes

604,978

750,156

Depreciation
Share-based payment expenses

146,240
6,963

104,1855,505Interest and dividend income
Interest expenses

(0)
1,971

(0)
2,407

Decrease (increase) in trade receivables
Decrease (increase) in inventories(74,569)(109,998)(53,463)(63,245)

Increase (decrease) in trade payables
Loss on retirement of non-current assets

22,69750

18,17357

Decrease (increase) in accounts receivable - other
Increase (decrease) in accounts payable - other(1,430)(7,742)

5,538
47,331

Increase (decrease) in accrued expenses
Increase/decrease in consumption taxes payable/consumption(5,041)

3,260(28,025)

24,725(10,002)(42,339)

Subtotal

546,090

802,293

Interest and dividends received
Interest paid0(1,934)0(2,488)

Income taxes paid

(195,526)(197,086)

Net cash provided by (used in) operating activities

348,629602,718

Purchase of property, plant and equipment
Purchase of intangible assets(103,087)(1,100)(110,958)–

Payments of guarantee deposits
Proceeds from refund of guarantee deposits

(312)
466

(180)
196

(104,033)(110,942)(368,238)(229,986)(306,762)
200,000(315,557)
200,000(5,657)(0)(4,937)–(480,658)(350,481)

taxes refund receivable
Other, net

Cash flows from investing activities

Net cash provided by (used in) investing activities
Cash flows from financing activities
Repayments of long-term borrowings
Dividends paid
Net increase (decrease) in short-term borrowings
Repayments of lease liabilities
Purchase of treasury shares
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents(236,061)

141,294

Cash and cash equivalents at beginning of period

2,518,589

2,516,212

Cash and cash equivalents at end of period

2,282,527

2,657,507

6